Journal of Child and Adolescent Psychopharmacology

Top Research Topics at Journal of Child and Adolescent Psychopharmacology?

The primary areas of discussion in Journal of Child and Adolescent Psychopharmacology are Psychiatry, Pediatrics, Clinical psychology, Attention deficit hyperactivity disorder and Internal medicine. The research on Psychiatry featured in it combines topics in other fields like Randomized controlled trial and MEDLINE. Most of the Randomized controlled trial studies addressed also intersect with Placebo.

The studies on Pediatrics discussed can also contribute to research in the domains of Clinical trial, Aripiprazole, Tolerability, Adverse effect and Olanzapine. Topics in Clinical psychology were tackled in line with various other fields like Autism, Aggression, Irritability and Anxiety. It focuses on Attention deficit hyperactivity disorder but the discussions also offer insight into other areas such as Stimulant and Rating scale.

The Internal medicine study featured in the journal draws parallels with the field of Endocrinology. Major depressive disorder is a major topic of Depression (differential diagnoses) research presented in Journal of Child and Adolescent Psychopharmacology. The studies tackled, which mainly focus on Bipolar disorder, apply to Mood as well.

• Psychiatry (56.20%)
• Pediatrics (24.18%)
• Clinical psychology (23.75%)

What are the most cited papers published in the journal?

• Functional impairment in children and adolescents with obsessive-compulsive disorder. (398 citations)
• DSM-IV Mania Symptoms in a Prepubertal and Early Adolescent Bipolar Disorder Phenotype Compared to Attention-Deficit Hyperactive and Normal Controls (294 citations)
• Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. (234 citations)

Research areas of the most cited articles at Journal of Child and Adolescent Psychopharmacology:

The journal papers tackle a plethora of topics, such as Psychiatry, Clinical psychology, Pediatrics, Attention deficit hyperactivity disorder and Bipolar disorder. The majority of Psychiatry studies in the most cited articles are focused on the issues of Risperidone. The most cited publications facilitate discussions on Clinical psychology that incorporate concepts from other fields like Rating scale, Anxiety, Autism, Depression (differential diagnoses) and Comorbidity.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Psychiatry

The previous edition focused in particular on these issues:

The foci of Journal of Child and Adolescent Psychopharmacology are Psychiatry, Pediatrics, Attention deficit hyperactivity disorder, Depression (differential diagnoses) and Letter to the editor. The journal primarily discusses Psychiatry topics, particularly Autism, Psychopharmacology, Mental health, Child and adolescent and Atomoxetine. While work presented in Journal of Child and Adolescent Psychopharmacology provided substantial information on Pediatrics, it also covered topics in MEDLINE, Antipsychotic, Tolerability, Medical prescription and Catatonia.

Journal of Child and Adolescent Psychopharmacology explores the study of Attention deficit hyperactivity disorder to improve our understanding of the broader topic of Clinical psychology. The journal holds forums on Clinical psychology that merges themes from other disciplines such as Clinical trial and Rating scale. The journal explores research in Anxiety and overlapping concepts in Obsessive compulsive to expand the discourse in Depression (differential diagnoses).

The most cited articles from the last journal are:

• CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review (4 citations)
• Aripiprazole in Children and Adolescents (3 citations)
• Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Journal of Child and Adolescent Psychopharmacology (based on the number of publications) are:

• Barbara J. Coffey (92 papers) published 6 papers at the last edition, 2 less than at the previous edition,
• Robert L. Findling (77 papers) published 1 paper at the last edition, 3 less than at the previous edition,
• Michael G. Aman (48 papers) absent at the last edition,
• L. Eugene Arnold (45 papers) absent at the last edition,
• Melissa P. DelBello (44 papers) published 2 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Child and Adolescent Psychopharmacology (based on the number of publications) are:

• Harvard University (89 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Ohio State University (73 papers) published 1 paper at the last edition, 4 less than at the previous edition,
• National Institutes of Health (73 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• University of California, Los Angeles (68 papers) published 1 paper at the last edition the same number as at the previous edition,
• Icahn School of Medicine at Mount Sinai (62 papers) published 6 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.12% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 23.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.36% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 22.73% of all publications and 42.05% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Child and Adolescent Psychopharmacology

It is imperative to note that the field of Child and Adolescent Psychopharmacology doesn't solely revolve around research and academic pursuits. It also offers a multitude of career opportunities for those interested in making a tangible impact within this specialty. One such path is becoming a Board Certified Behavior Analyst (BCBA).

The BCBA is a globally recognized certification for professionals who practice applied behaviour analysis, particularly within the context of child and adolescent mental health. The role includes conducting behavioral assessments, analyzing data, training others to implement effective interventions, and developing treatment plans for clients with behavioral disorders. It is a path that encompasses both the theoretical understandings researched in this journal and the practical applications that can change lives.

Acquiring the BCBA certification involves a structured sequence of steps including relevant undergraduate studies, a master's degree in Psychology or a closely related field, specific coursework in behavior analysis, supervised practical experience, and passing the BCBA certification exam. Each U.S. state may also have specific rules and regulations for practicing BCBAs.

If you want a deep dive on the process, reading about firsthand experiences and practical tips can be extremely helpful. For example, learn how to become a BCBA in Louisiana. While laws may vary, the central process remains quite synonymous, providing useful insights to prospective BCBAs across regions.

Becoming a BCBA can open doors within clinical practice, consultation roles, research, and academia, offering diverse paths to utilize the knowledge and skills gained from Child and Adolescent Psychopharmacology studies.